|
|
Issue
|
Alert me when new journal issues are available via  or via  |
|
|
| Urologic Oncology: Seminars and Original Investigations |
| Volume 26, Issue 4, Pages 337-450 (July-August 2008) |
|
Search Within This Issue
|
| Evolving New Treatments For Patients With Prostate Cancer: The Advanced Disease Paradigm of the PSA Era
|
| Edited by Mario A. Eisenberger MD |
|
|
|
|
|
|
|
Masthead
page ii
Full-Text PDF (32 KB)
|
|
Editorial Board
page iii
Full-Text PDF (65 KB)
|
|
Contents
pages iv-vi
Full-Text PDF (55 KB)
|
|
|
News and Topics
|
|
Biopsy of the small renal mass: Time to shift the clinical paradigm?
Seth A. Strope, J. Stuart Wolf
pages 337-338
Full Text |
Full-Text PDF (59 KB)
|
|
|
Translational Studies in Urologic Oncology
|
|
Understanding intravesical BCG: A window to the future treatment of noninvasive bladder cancer
Kevin R. Loughlin
pages 339-340
Full Text |
Full-Text PDF (54 KB)
|
|
Role of neutrophils in BCG immunotherapy for bladder cancer
Mark P. Simons, Michael A. O'Donnell, Thomas S. Griffith
pages 341-345
Abstract |
Full Text |
Full-Text PDF (100 KB)
|
|
|
Review Article
|
|
The once and future role of cytoreductive nephrectomy, 15 January 2008
Mischel G. Neill, Michael A.S. Jewett
pages 346-352
Abstract |
Full Text |
Full-Text PDF (110 KB)
|
|
|
Original Articles
|
|
Are PSA density and PSA density of the transition zone more accurate than PSA in predicting the pathological stage of clinically localized prostate cancer?, 14 December 2007
Gianluca Giannarini, Cathryn A. Scott, Umberto Moro, Barbara Pertoldi, Carlo A. Beltrami, Cesare Selli
pages 353-360
Abstract |
Full Text |
Full-Text PDF (704 KB)
|
|
Familial pheochromocytoma, 14 December 2007
Mary A. Bissada, Ahmed S. Safwat, Raouf M. Seyam, Saif Al Sobhi, Kamal A. Hanash, Nabil K. Bissada
pages 361-363
Abstract |
Full Text |
Full-Text PDF (68 KB)
|
|
Effect of perioperative blood transfusion on prostate cancer recurrence, 09 November 2007
Beneranda S. Ford, Satish Sharma, Hamed Rezaishiraz, Robert S. Huben, James L. Mohler
pages 364-367
Abstract |
Full Text |
Full-Text PDF (101 KB)
|
|
Ductal prostate cancer: Contemporary management and outcomes, 10 December 2007
Eduardo Orihuela, Justin M. Green
pages 368-371
Abstract |
Full Text |
Full-Text PDF (83 KB)
|
|
Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity, 10 January 2008
Joshua H. Petit, Clifford Gluck, W.S. Kiger, D. Laury Henry, Carol Karasiewicz, James Talcott, Solomon Berg, Edward Holupka, Irving Kaplan
pages 372-377
Abstract |
Full Text |
Full-Text PDF (244 KB)
|
|
(Z)-1,1-Dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane induces concentration-dependent growth inhibition, apoptosis, and coordinates regulation of apoptotic genes in TRAMP cells, 14 December 2007
Catherine A. Thomas, Stephen G. Grant, Beth R. Pflug, Robert H. Getzenberg, Billy W. Day
pages 378-385
Abstract |
Full Text |
Full-Text PDF (285 KB)
|
|
Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells, 15 January 2008
Gaynor Davies, Tracey A. Martin, Lin Ye, Jonathon M. Lewis-Russell, Malcolm D. Mason, Wen G. Jiang
pages 386-391
Abstract |
Full Text |
Full-Text PDF (262 KB)
|
|
Chemical castration with intratesticular injection of 20% hypertonic saline: A minimally invasive method, 30 November 2007
Levent Emir, Mümtaz Dadalı, Melih Sunay, Demokan Erol, Muzaffer Çaydere, Hüseyin Üstün
pages 392-396
Abstract |
Full Text |
Full-Text PDF (1080 KB)
|
|
ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer, 15 January 2008
Weiguo Chen, Chunyin Yan, Jianquan Hou, Jinxian Pu, Jun Ouyang, Duangai Wen
pages 397-405
Abstract |
Full Text |
Full-Text PDF (670 KB)
|
|
|
Seminar Section Introduction
|
|
Evolving new treatments for patients with prostate cancer: The advanced disease paradigm of the PSA era
Mario A. Eisenberger
pages 406-407
Full Text |
Full-Text PDF (122 KB)
|
|
|
Seminar Articles
|
|
Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era
Fernando J. Bianco
pages 408-414
Abstract |
Full Text |
Full-Text PDF (192 KB)
|
|
Hormonal approaches in prostate cancer: Application in the contemporary prostate cancer patient
Kathleen W. Beekman, Maha Hussain
pages 415-419
Abstract |
Full Text |
Full-Text PDF (90 KB)
|
|
Osteoclast targeted therapy for prostate cancer: Bisphosphonates and beyond
Matthew R. Smith
pages 420-425
Abstract |
Full Text |
Full-Text PDF (99 KB)
|
|
Current status of cytotoxic chemotherapy in patients with metastatic prostate cancer
Robert Dreicer
pages 426-429
Abstract |
Full Text |
Full-Text PDF (84 KB)
|
|
New drug development in metastatic prostate cancer
Andrew J. Armstrong, Daniel J. George
pages 430-437
Abstract |
Full Text |
Full-Text PDF (285 KB)
|
|
Immunotherapy for metastatic prostate cancer, 14 December 2007
Charles G. Drake
pages 438-444
Abstract |
Full Text |
Full-Text PDF (113 KB)
|
|
Survey Section Editorial Board
page 445
Full-Text PDF (37 KB)
|
|
|
Urologic Oncology Survey
|
|
Does prophylactic breast irradiation on patients with prostate cancer influence cardiac toxicity? Nieder C, Pawinski A, Andratschke NH, Molls M, Department of Internal Medicine Radiation Oncology Unit, Nordlandssykehuset HF, Bodø, Norway; Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
Joycelyn L. Speight
page 446
Abstract |
Full Text |
Full-Text PDF (58 KB)
|
|
An update of the Phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: Updated analysis of RTOG 94-13 with emphasis on unexpected hormone/radiation interactions: Lawton CA, DeSilvio M, Roach M III, Uhl V, Kirsch R, Seider M, Rotman M, Jones C, Asbell S, Valicenti R, Hahn S, Thomas CR Jr., Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI.
Joycelyn L. Speight
pages 446-447
Abstract |
Full Text |
Full-Text PDF (64 KB)
|
|
Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy: Weiss C, Wittlinger M, Engehausen DG, Krause FS, Ott OJ, Dunst J, Sauer R, Rödel C, Department of Radiation Therapy, University of Erlangen, Erlangen, Germany.
Joycelyn L. Speight
pages 447-448
Abstract |
Full Text |
Full-Text PDF (44 KB)
|
|
Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer: Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL, Mark A. Ritter, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA.
Mark A. Ritter
pages 448-449
Abstract |
Full Text |
Full-Text PDF (40 KB)
|
|
Information for Authors
page IBC
Full-Text PDF (34 KB)
|
|
|
|
|
